Cylap® vaccine is an adjuvanted vaccine containing inactivated rabbit calicivirus.
Recommendations for use:
For the control of rabbit calicivirus disease in european rabbits.
10 mL vial containing 10 doses.
- Inactivation of the vaccine assures no replication of vaccine virus.
- Studies show protection against both RHDV v351 strain and RHDV K5 strain.
- 1 mL initial vaccination dose by subcutaneous route.
- Rabbits should be vaccinated at 2½-3 months of age.
- If epizootic conditions make vaccination advisable before the age of ten weeks then animals should be re-vaccinated one month after the first innoculation or when they reach the age of 2½-3 months, whichever occurs first.
- An annual booster vaccination is recommended.
Store between 2°C and 8°C (Refrigerate. Do not freeze). Protect from light.
Additional user safety
User Safety Information:
Take care to avoid accidental self-injection.
This product contains mineral oil. In the event of self-injection, seek prompt medical attention and take this package leaflet/carton with you. Accidental self-injection may result in local bruising, severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result on the loss of the affected finger if prompt medical attention is not given. If pain persists for more than 12 hours after medical examination, seek medical advice.
Ancillary Advice to the Medical Practitioner:
This product contains mineral oil. Even if small amounts of this product have been accidentally self-injected, it can cause intense swelling and a persistent granulomatous inflammatory reaction. If injected into a finger joint or tendon sheath, the product may track along the tendon. The swelling and inflammation may compromise blood supply and result in necrosis that, in rare cases, may lead to the loss of a digit. Following appropriate immediate local cleansing, corticosteroids may be considered to decrease the severity of any local reaction. Ascertain the patient’s tetanus immunization status, and provide booster or primary series, as appropriate. In some cases of accidental self-injection PROMPT surgical attention may be required. The wound should be incised and irrigated to remove the vaccine, especially where there is involvement of finger pulp or tendon. Complete curettage or total excision of the lesion may be required for chronic granulomatous reactions. Meticulous technique is required to stop inadvertent spread of the product.
First Aid Statement
If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131126; of New Zealand 0800 POISON (0800 764 766).
This material may cause a mild allergic reaction in sensitive individuals on skin contact. Avoid skin contact. If skin or hair contact occurs, remove contaminated clothing and flush skin and hair with running water. If splashed in eyes, wash out immediately with water.
Additional information is provided in the Material Safety Data Sheet.
Registered label warnings
Withholding Period: NIL
To be used by, or under the direction of a registered veterinary surgeon.
Rabbits in good health should be immunised when they are least likely to be environmentally stressed by extremes of temperature or humidity. A small number of animals in any population may fall to respond to vaccination as a result of immunological incompetence or for some other reason. Some breeds of European rabbits, particularly dwarf rabbits, may respond differently to vaccination due to their specific genetic profile.
In a small number of vaccinated animals a localised injection site reaction may occur. This may be seen as a swelling and/or alopecia (loss of hair). Some rabbits may show a transient general malaise. As with all immunobiologicals and chemotherapeutics, occasional hypersensitivity reactions such as anaphylaxis may occur. In such an event these rabbits should be treated without delay by the parenteral administration of antihistamines, corticosteroids or adrenalin as is appropriate.
Cylap RCD Vaccine contains inactivated rabbit calicivirus,
- Belgium (French)
- Belgium (Dutch)
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.